Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Anika Therapeutics (ANIK) Long-Term Deferred Tax (2018 - 2025)

Historic Long-Term Deferred Tax for Anika Therapeutics (ANIK) over the last 9 years, with Q3 2025 value amounting to $1.3 million.

  • Anika Therapeutics' Long-Term Deferred Tax fell 1501.36% to $1.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.3 million, marking a year-over-year decrease of 1501.36%. This contributed to the annual value of $1.2 million for FY2024, which is 2095.37% down from last year.
  • Anika Therapeutics' Long-Term Deferred Tax amounted to $1.3 million in Q3 2025, which was down 1501.36% from $1.3 million recorded in Q2 2025.
  • In the past 5 years, Anika Therapeutics' Long-Term Deferred Tax ranged from a high of $1.5 million in Q1 2023 and a low of $1.2 million during Q4 2024
  • Moreover, its 4-year median value for Long-Term Deferred Tax was $1.4 million (2023), whereas its average is $1.4 million.
  • Within the past 5 years, the most significant YoY rise in Anika Therapeutics' Long-Term Deferred Tax was 337.08% (2024), while the steepest drop was 2095.37% (2024).
  • Quarter analysis of 4 years shows Anika Therapeutics' Long-Term Deferred Tax stood at $1.4 million in 2022, then rose by 2.76% to $1.5 million in 2023, then fell by 20.95% to $1.2 million in 2024, then grew by 6.29% to $1.3 million in 2025.
  • Its Long-Term Deferred Tax was $1.3 million in Q3 2025, compared to $1.3 million in Q2 2025 and $1.2 million in Q1 2025.